Physician profile
Donna A Eubanks
NPI 1043641178
$1,752.22
in general payments reported to CMS, 2019-2025
19 companies · $627 in 2025
The $627 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.18 · 2022: $256 · 2023: $235 · 2024: $605 · 2025: $627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,457 · Consulting Fee: $9.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,457.02 |
| Consulting Fee | $9.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $647.77 | 2022-2025 | Tezspire, Fasenra, Airsupra |
| Genzyme Corporation | $185.18 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $138.66 | 2024-2025 | |
| Csl Behring | $130.49 | 2022-2025 | Andembry, Haegarda, Hizentra |
| Takeda Pharmaceuticals U.S.A., INC. | $110.63 | 2022-2025 | Cuvitru, Takhzyro |
| Galderma Laboratories, L.P. | $94.90 | 2025 | Nemluvio |
| Leo Pharma INC. | $84.03 | 2023-2025 | Adbry |
| Amgen INC. | $70.65 | 2022-2025 | Tezspire |
| Grifols USA, LLC | $68.01 | 2024 | Xembify |
| Biocryst US Sales Co., LLC | $48.18 | 2023-2024 | Orladeyo |
| Genentech USA, INC. | $30.55 | 2024 | Xolair |
| Glaxosmithkline, LLC. | $25.05 | 2025 | Trelegy Ellipta |
| Teva Pharmaceuticals USA, INC. | $23.40 | 2022 | |
| Pharmacosmos Therapeutics INC. | $18.98 | 2022 | |
| Kedrion Biopharma, INC. | $18.30 | 2025 | Gammaked, Koate, Kedrab |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $17.58 | 2025 | Ruconest |
| Regeneron Healthcare Solutions, INC. | $16.58 | 2022 | |
| Bio Products Laboratory USA, INC. | $13.57 | 2022-2023 | Gammaplex, Coagadex |
| Adma Biomanufacturing LLC | $9.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Eubanks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.